Document is current

Any future updates will be listed below

Second-Line Therapy for Advanced Colorectal Cancer: EGFR vs. Continuation of VEGF Inhibition

Crossref DOI link: https://doi.org/10.1007/s11888-017-0388-z

Published Online: 2017-09-18

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark